GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Gencurix Inc (XKRX:229000) » Definitions » Gross Profit

Gencurix (XKRX:229000) Gross Profit : ₩1,667 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Gencurix Gross Profit?

Gencurix's gross profit for the three months ended in Mar. 2024 was ₩568 Mil. Gencurix's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was ₩1,667 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Gencurix's gross profit for the three months ended in Mar. 2024 was ₩568 Mil. Gencurix's Revenue for the three months ended in Mar. 2024 was ₩816 Mil. Therefore, Gencurix's Gross Margin % for the quarter that ended in Mar. 2024 was 69.63%.

Gencurix had a gross margin of 69.63% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 7 years, the highest Gross Margin % of Gencurix was 57.53%. The lowest was -97.73%. And the median was 25.57%.


Gencurix Gross Profit Historical Data

The historical data trend for Gencurix's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gencurix Gross Profit Chart

Gencurix Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial 8.07 -1,250.19 -2,977.79 1,157.77 1,348.24

Gencurix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 249.66 269.99 636.53 192.06 568.16

Competitive Comparison of Gencurix's Gross Profit

For the Diagnostics & Research subindustry, Gencurix's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gencurix's Gross Profit Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Gencurix's Gross Profit distribution charts can be found below:

* The bar in red indicates where Gencurix's Gross Profit falls into.



Gencurix Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Gencurix's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=2600.318 - 1252.08
=1,348

Gencurix's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=815.961 - 247.799
=568

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,667 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Gencurix's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=568 / 815.961
=69.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Gencurix  (XKRX:229000) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Gencurix had a gross margin of 69.63% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Gencurix Gross Profit Related Terms

Thank you for viewing the detailed overview of Gencurix's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Gencurix (XKRX:229000) Business Description

Traded in Other Exchanges
N/A
Address
9th Floor, Hanhwa Bizmetro I, Guro 3-dong, Guro-gu, Seoul, KOR, 152-733
Gencurix Inc develops diagnosis treatment kits. It offers products including GenesWell BCT, a breast cancer test; GenesWell ddEGFR Mutation Test; GenesWell CDx EGFR Mutation Test; and GenesWell ddEGFR mutation Test.

Gencurix (XKRX:229000) Headlines

No Headlines